Target intelligence / Profile preview

Mitochondrial oxidative phosphorylation machinery (OXPHOS machinery)

Target
OXPHOS machinery
Molecular classification
Enzyme complex, Multi-subunit protein complex, Mitochondrial protein complex, Energy metabolism machinery
01

Overview

The **mitochondrial oxidative phosphorylation machinery** (OXPHOS machinery) consists of a series of multi-subunit protein complexes—Complex I (NADH-ubiquinone oxidoreductase), Complex II (succinate-ubiquinone oxidoreductase), Complex III (ubiquinone-cytochrome c oxidoreductase), Complex IV (cytochrome c oxidase), and ATP synthase—embedded in the mitochondrial inner membrane[1][4][2][3]. These complexes operate in concert to transfer electrons from metabolic substrates (NADH, FADH2) through the electron transport chain, pumping protons across the inner membrane to generate a proton motive force. This gradient is then used by ATP synthase to convert ADP and inorganic phosphate into ATP, the main cellular energy currency[2][1][4]. Dysfunction or genetic alterations in OXPHOS components lead to a broad spectrum of diseases, including inherited mitochondrial disorders, neurodegeneration, certain cancers, and heart diseases[1][3]. Exposure to environmental toxins, certain drugs, or mutations can inhibit or disrupt the function of these complexes, causing impaired energy production and elevated oxidative stress. OXPHOS machinery is considered a core therapeutic target for modulating bioenergetics in cancer, metabolic disorders, and aging-related conditions, but targeting this system also carries significant safety risks due to its fundamental role in cellular metabolism[1][3][4]. **Note:** - This target is often considered *too broad* for therapeutic purposes, as it represents a collection of complexes and enzymes rather than a single protein. Individual complexes (e.g., Complex I, ATP synthase) are usually targeted specifically, not the whole machinery at once[2][4]. - "Mitochondrial oxidative phosphorylation machinery" is not a standardized name for a single molecular entity, but refers to a collective system, which compromises specificity for drug targeting and biomarker selection[1][3].

Other names
oxidative phosphorylation systemmitochondrial respiratory chainelectron transport chain (when referencing the subcomponents)OXPHOS system
02

Mechanism of action

Inhibition of electron transport chain complexes (I–IV); Inhibition of ATP synthase; Uncoupling oxidative phosphorylation (proton gradient dissipation); Modulation of ROS production

03

Biological functions

ATP synthesisEnergy metabolismReactive oxygen species (ROS) productionCellular signalingRegulation of cell death
04

Disease associations

Mitochondrial diseaseCancerNeurodegenerative diseaseCardiovascular diseaseAging-related diseaseMetabolic syndrome
05

Safety considerations

Mitochondrial toxicityLactic acidosisImpaired energy metabolism in non-target tissuesOff-target organ effects (e.g., neurotoxicity, myopathy)ROS-induced damage
06

Interacting drugs

Metformin

7 more in the full profile.

07

Biomarkers

Lactate/pyruvate ratioMitochondrial DNA mutations/deletionsATP levelsOxygen consumption rate (OCR)ROS levels

Beyond the preview

Go deeper on Mitochondrial oxidative phosphorylation machinery (OXPHOS machinery).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial oxidative phosphorylation machinery (OXPHOS machinery).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call